User profiles for Gemma Figtree
 | Gemma FigtreeProfessor, Sydney Medical School (Northern), University of Sydney Verified email at sydney.edu.au Cited by 17972 |
Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European …
…, MN Sheppard, GA Figtree… - European journal of …, 2016 - Wiley Online Library
Takotsubo syndrome is an acute reversible heart failure syndrome that is increasingly
recognized in modern cardiology practice. This Position Statement from the European Society of …
recognized in modern cardiology practice. This Position Statement from the European Society of …
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data
GA Figtree, ST Vernon, N Hadziosmanovic… - The Lancet, 2021 - thelancet.com
Background In cardiovascular disease, prevention strategies targeting standard modifiable
cardiovascular risk factors (SMuRFs; hypertension, diabetes, hypercholesterolaemia, and …
cardiovascular risk factors (SMuRFs; hypertension, diabetes, hypercholesterolaemia, and …
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
[HTML][HTML] Biological markers of oxidative stress: applications to cardiovascular research and practice
Oxidative stress is a common mediator in pathogenicity of established cardiovascular risk
factors. Furthermore, it likely mediates effects of emerging, less well-defined variables that …
factors. Furthermore, it likely mediates effects of emerging, less well-defined variables that …
[PDF][PDF] The global burden of metabolic disease: Data from 2000 to 2019
Global estimates of prevalence, deaths, and disability-adjusted life years (DALYs) from the
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …
Canagliflozin and heart failure in type 2 diabetes mellitus: results from the CANVAS program
Background: Canagliflozin is a sodium glucose cotransporter 2 inhibitor that reduces the
risk of cardiovascular events. We report the effects on heart failure (HF) and cardiovascular …
risk of cardiovascular events. We report the effects on heart failure (HF) and cardiovascular …
[HTML][HTML] The health digital twin to tackle cardiovascular disease—a review of an emerging interdisciplinary field
G Coorey, GA Figtree, DF Fletcher, VJ Snelson… - NPJ digital …, 2022 - nature.com
Potential benefits of precision medicine in cardiovascular disease (CVD) include more
accurate phenotyping of individual patients with the same condition or presentation, using …
accurate phenotyping of individual patients with the same condition or presentation, using …
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with …
…, A Edison, AE Abraham, D Xu, MT Bloch, G Figtree… - The Lancet, 2021 - thelancet.com
Background Treatment inertia is a recognised barrier to blood pressure control, and simpler,
more effective treatment strategies are needed. We hypothesised that a hypertension …
more effective treatment strategies are needed. We hypothesised that a hypertension …
Reversible Oxidative Modification: A Key Mechanism of Na+-K+ Pump Regulation
GA Figtree, CC Liu, S Bibert, EJ Hamilton… - Circulation …, 2009 - Am Heart Assoc
Angiotensin II (Ang II) inhibits the cardiac sarcolemmal Na + -K + pump via protein kinase (PK)C-dependent
activation of NADPH oxidase. We examined whether this is mediated by …
activation of NADPH oxidase. We examined whether this is mediated by …
[HTML][HTML] Cardiac spheroids as promising in vitro models to study the human heart microenvironment
Three-dimensional in vitro cell systems are a promising alternative to animals to study cardiac
biology and disease. We have generated three-dimensional in vitro models of the human …
biology and disease. We have generated three-dimensional in vitro models of the human …